About

Ibogaine Treatment Program is an independent resource on ibogaine for people researching ibogaine. We gather evidence, explain safety and legal issues, and organize practical questions so readers can make informed choices.

This page describes who we are, how we work, and the editorial standards that guide our content.

Close view of hands and documents during a careful consultation about ibogaine treatment

Our editorial approach

We publish for people researching ibogaine; our role is informational, not clinical. Our work combines summaries of peer-reviewed literature and public registries with plain-language explanations about how evidence and safety considerations are assessed.

Where helpful, our articles link to primary sources and regulatory guidance so readers can trace claims back to original documents; for example, widely referenced clinical summaries are often indexed on authoritative pages such as the National Library of Medicine on PubMed (Wikipedia's ibogaine overview) and official registry entries on government health sites like the U.S. National Institutes of Health (nih.gov).

"Independence and clarity: our editorial work is designed to reduce confusion for people evaluating complex, high-stakes options."

What we cover

We focus on the organizational aspects of information: what questions people ask, how evidence is collected, and where to find primary documents. Content areas include summaries of safety literature, legal and access considerations, and practical procedural descriptions written for a general audience.

If you are orienting yourself on options and want an overview of services mentioned on this site, our Services page offers structured descriptions and links to informational resources; we reference that in contextual editorial pieces so readers can compare pathways in one place (review our services descriptions).

Evidence summaries

Concise, sourced summaries of peer-reviewed studies and observational reports with clear links to the original publications.

Safety & risks

Plain-language explanations of commonly reported harms, monitoring needs, and risk mitigation strategies drawn from official guidance.

Legal context

Guides to how regulation and access differ by jurisdiction and what that means for people researching options.

How information is sourced and vetted

We combine systematic searches of the scientific literature with consultation of registries and official documents. Where appropriate we cite clinical trial registries, government health advisories, and academic reviews to triangulate claims. For transparency, articles include links to the primary sources we used so readers can verify context.

Editorial checks include source attribution, evaluation of study design, and noting conflicts or gaps in the evidence base. For general standards on assessing medical evidence we reference established frameworks such as those presented by universities and public health bodies (Cochrane).

Editorial principles

  • Independence — we do not accept funding that dictates editorial conclusions.
  • Plain language — technical content is translated into usable explanations.
  • Evidence-first — claims are supported by citations and source notes.
  • Audience-focused — we write for people researching ibogaine, not clinicians.
Hands reviewing printed scientific literature and notes for editorial vetting

Who this is for

Our audience is people researching ibogaine who need balanced, sourced information to inform personal decisions or further research. We do not provide clinical recommendations, diagnosis, or legal advice. If you need medical or legal guidance, consult licensed professionals in your jurisdiction.

To explore organizations listing services and logistical options, readers sometimes consult external directories; when such directories are mentioned, we link to them contextually and do not endorse specific providers — for example, third-party directories consolidate regional listings (best ibogaine treatment centers directory).

Independent by design

Ibogaine Treatment Program is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.

Values

Independence · Plain language · Audience-specific evidence · No fabricated credentials

Explore the site or return to our main hub for topical content and organized guides.

Visit the main hub

Quick policies

  • No endorsements of clinics or providers.
  • No invented credentials or staff biographies.
  • Sources cited where claims are made; primary documents linked where available.

FAQ

Is Ibogaine Treatment Program a clinic?
No. Ibogaine Treatment Program is an independent information resource and is not a clinic, medical provider, or licensed treatment center.
Where can I find service listings referenced in articles?
Where we reference third-party directories or listings, links are embedded contextually in the relevant article text; readers who want a compact directory view may consult external directories such as the best ibogaine treatment centers directory linked within explanatory pieces.
How do you choose external sources?
We prioritise peer-reviewed studies, official registries, and recognized evidence-synthesis organizations; for methodological guidance we refer to established authorities such as Cochrane (cochrane.org) and public health sites like the National Institutes of Health (nih.gov).
How can I contact the editorial team?
See our Contact page for available channels and guidance on inquiries — our Contact page describes how to reach the brand and what to expect in response (contact details and process).